Urine biomarkers to predict response to lupus nephritis therapy in children and young adults
HI Brunner, MR Bennett, G Gulati, K Abulaban… - The Journal of …, 2017 - jrheum.org
Objective. To delineate urine biomarkers that forecast response to therapy of lupus nephritis
(LN). Methods. Starting from the time of kidney biopsy, patients with childhood-onset …
(LN). Methods. Starting from the time of kidney biopsy, patients with childhood-onset …
Dissecting the histological features of lupus nephritis highlights new common patterns of injury in class III/IV
Objective The International Society of Nephrology/Renal Pathology Society classification is
the gold standard for the characterisation of lupus nephritis (LN) on renal biopsy, with …
the gold standard for the characterisation of lupus nephritis (LN) on renal biopsy, with …
Transcriptomic profiling in human mesangial cells using patient-derived lupus autoantibodies identified miR-10a as a potential regulator of IL8
P Tangtanatakul, B Thammasate, A Jacquet… - Scientific Reports, 2017 - nature.com
Autoantibody-mediated inflammation directed at resident kidney cells mediates lupus
nephritis (LN) pathogenesis. This study investigated the role of miRNA in human mesangial …
nephritis (LN) pathogenesis. This study investigated the role of miRNA in human mesangial …
Outcomes of membranous and proliferative lupus nephritis–analysis of a single-centre cohort with more than 30 years of follow-up
F Farinha, RJ Pepper, DG Oliveira, T McDonnell… - …, 2020 - academic.oup.com
Objectives To compare membranous lupus nephritis (MLN) and proliferative lupus nephritis
(PLN) with respect to survival, demographic, clinical and laboratory characteristics; and to …
(PLN) with respect to survival, demographic, clinical and laboratory characteristics; and to …
Risk of chronic kidney disease in 260 patients with lupus nephritis: analysis of a nationwide multicentre cohort with up to 35 years of follow-up
F Farinha, S Barreira, M Couto, M Cunha… - …, 2024 - academic.oup.com
Objectives To compare proliferative (PLN) and membranous (MLN) lupus nephritis (LN)
regarding clinical and laboratory presentation and long-term outcomes, and to investigate …
regarding clinical and laboratory presentation and long-term outcomes, and to investigate …
Clinical characteristics and long-term outcomes in patients with mixed Class III/IV+ V and pure proliferative lupus nephritis: A single-center experience
SS Ahn, J Yoo, SW Lee, JJ Song, YB Park, SM Jung - Lupus, 2022 - journals.sagepub.com
Objectives Proliferative lupus nephritis (LN) is a crucial complication in systemic lupus
erythematosus (SLE). This study evaluated the clinical implications of coexistence of …
erythematosus (SLE). This study evaluated the clinical implications of coexistence of …
[HTML][HTML] 狼疮性肾炎不同病理分型的疾病活动性及终末期肾病的危险因素分析
吴奇俊， 张东梅， 翟志芳， 宋志强 - 2020 - aammt.tmmu.edu.cn
目的分析狼疮性肾炎(lupus nephritis, LN) 患者不同病理分型与临床疾病活动性和预后的关系,
以及终末期肾病(end-stage renal disease, ESRD) 的危险因素. 方法回顾性分析本院2013 …
以及终末期肾病(end-stage renal disease, ESRD) 的危险因素. 方法回顾性分析本院2013 …
Estresse oxidativo na lesão renal de pacientes com lúpus eritematoso sistêmico
F Tiecher, GS da Silva… - … A LAS CIENCIAS …, 2024 - ojs.revistacontribuciones.com
O Lúpus Eritematoso Sistêmico (LES) é uma doença autoimune crônica com alta
prevalência global, afetando principalmente mulheres jovens de origem afro-americana …
prevalência global, afetando principalmente mulheres jovens de origem afro-americana …
[PDF][PDF] Estresse oxidativo na lesão renal de pacientes com lúpus eritematoso sistêmico Oxidative stress in kidney injury in patients with systemic lupus erythematosus
F Tiecher, GS da Silva, RC da Cunha - scholar.archive.org
ABSTRACT Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease with a
high global prevalence, affecting mainly young women of African-American, Hispanic and …
high global prevalence, affecting mainly young women of African-American, Hispanic and …
[PDF][PDF] Department of Human Pharmacology and Toxicology
T Mitsou - theses.cz
Systemic lupus erythematosus (SLE) is a prototypic, chronic, autoimmune disease, of
variable severity with altering periods of flares and remissions and a multisystem character …
variable severity with altering periods of flares and remissions and a multisystem character …